Project Grant R21HD112910
Award Date
9/5/23
Completion Date
8/31/25
Dollars Obligated
$428K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on developing novel biomarkers to assess plexiform neurofibroma tumor burden in individuals with neurofibromatosis type 1 (NF1). The $734,542 award to the Ann & Robert H. Lurie Children's Hospital of Chicago will support analytical validation studies of candidate...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $877,001 to The Washington University to conduct research on modeling neurofibromatosis-1 (NF1) disease heterogeneity. The goal is to mechanistically define the cellular and molecular interdependencies underlying NF1-associated low-grade gliomas and neurodevelopmental deficits, and...
This Project Grant award of $1,819,296.00, issued by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund research to unravel the genomic causes for unsolved leukodystrophy patients. The award will utilize long-read genome sequencing (HiFi-GS) to identify complex genetic variants, such as repeat expansions and structural variants, that are often missed by standard short-read genome...
This Project Grant award of $1,106,142, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to identify mechanisms of neurofilament regulation and turnover in amyotrophic lateral sclerosis (ALS). The key objectives are to: 1) Develop advanced proteomic assays to analyze neurofilament isoforms and post-translational modifications in ALS, 2)...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $201,875 to Duke University to conduct research on the developmental origins of Sturge Weber Syndrome (SWS). The goal is to identify the specific fetal cell type and developmental timeframe in which the causative somatic mutation occurs, in order to generate a faithful animal...
The National Institute of Child Health and Human Development (NICHD) awarded a $344,357 Project Grant under CFDA 93.865 - Child Health and Human Development Extramural Research to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab) to validate non-linguistic laboratory biomarkers for detecting depression in individuals with aphasia. The study aims to assess the ability of three laboratory tests - heart rate variability, pupil dilation, and gaze duration - to...
The Washington University Office of Sponsored Research Services Division received a $427,625 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research to unravel the role of satellite glial cells in sensory hypersensitivity in Fragile X Syndrome, a leading genetic cause of autism spectrum disorders. Key activities include: Examining how...
This Project Grant award of $1,254,291.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to identify germline modifiers of neurofibromatosis type 1 (NF1) tumors. The research, conducted by a multidisciplinary team at the Cincinnati Children's Hospital Medical Center, aims to expand the understanding of genetic factors that influence the...
The National Institute of Child Health and Human Development (NICHD) awarded a $1,802,392 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. The goal of this 5-year grant, awarded on August 16, 2024, is to improve methods for identifying genetic contributors to rare diseases, especially neurodevelopmental disorders in children, using long-read genome sequencing technology. The...
This Project Grant award of $4,361,625 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a "VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD" at Washington University. The project aims to leverage advanced multi-omics and transcriptomic technologies to investigate the complex mechanisms underlying cerebral small vessel disease (CSVD) and its vascular contributions to dementia (VCID). Key...